Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4128 USD | +1.79% | +1.63% | -93.84% |
16/04 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
- Stock Market
- Equities
- GRI Stock
- News GRI BIOPAR
- Trading Ideas